Hot Watch List: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), AmSurg Corp. (NASDAQ:AMSG), ICF International Inc. (NASDAQ:ICFI),

Orexigen Therapeutics, Inc. (NASDAQ:OREX) is set to issue its Q415 quarterly earnings data on Friday, February 26th.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) belongs to Healthcare sector. Its weekly performance is -18.02%. On last trading day company shares ended up at $1.41. Orexigen Therapeutics, Inc. (NASDAQ:OREX) distance from 50-day simple moving average (SMA50) is 5.22%.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) announced that it plans to present the complete 18-month patisiran OLE data in an oral presentation at the American Academy of Neurology (AAN) annual meeting on April 20, 2016 in Vancouver, Canada.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares moved down -2.00% in last trading session and ended the day at $56.86. ALNY return on assets is -19.40%. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) quarterly performance is -45.60%.

AmSurg Corp. (NASDAQ:AMSG) announced financial results for the fourth quarter and year ended December 31, 2015. Growth of 21% in net revenues to $704.3 million from $581.8 million for the fourth quarter of 2014.

On 25 February, AmSurg Corp. (NASDAQ:AMSG) shares moved down -1.37% and was closed at $70.51. AMSG EPS growth in last 5 year was -5.00%. AmSurg Corp. (NASDAQ:AMSG) year to date (YTD) performance is -7.22%.

ICF International Inc. (NASDAQ:ICFI) will release its fourth quarter and full year 2015 results on Monday, March 7, 2016, after the market close.

ICF International Inc. (NASDAQ:ICFI) ended the last trading day at $32.93. Company weekly volatility is calculated as 1.89% and price to cash ratio as 111.04. ICF International Inc. (NASDAQ:ICFI) showed a weekly performance of -0.36%.

Anika Therapeutics Inc. (NASDAQ:ANIK) said that, its Board of Directors authorized a $25 million accelerate share repurchase program which the company expects to be completed in the third quarter of 2016.

Anika Therapeutics Inc. (NASDAQ:ANIK) shares increased 8.02% in last trading session and ended the day at $43.37. ANIK Gross Margin is 76.20% and its return on assets is 13.40%. Anika Therapeutics Inc. (NASDAQ:ANIK) quarterly performance is 5.04%.

Leave a Reply

Your email address will not be published. Required fields are marked *